NL-OMON48761已完成2 期
F18-PSMA-1007 PET for early biochemical recurrence of prostate cancer, comparison with 18F-Fluciclovine. - F18-PSMA-1007 PET for early biochemical recurrence of prostate cancer.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Males * 18 years
- •- Histologically proven adenocarcinoma of the prostate
- •- Prior local treatment with curative intent
- •- Biochemical recurrence with (rising) PSA-levels of 0.2-5.0 ug/L
- •- PSA level determined <8 weeks before study participation
排除标准
- •- Contra-indications for PET-CT: claustrophobia or inability to lay still for the duration of the exam
- •- Other cancer < 2 years prior to biochemical recurrence
研究者
相似试验
进行中（未招募）
1 期
F18-PSMA-1007 PET for early biochemical recurrence of prostate cancer.EUCTR2018-001267-22-NLRadboud University Medical Center50
Unknown
不适用
F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate CancerProstate Cancer RecurrentNCT04239742Radboud University Medical Center50
已完成
不适用
Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image FeaturesProstate CancerNCT06604377Ruijin Hospital203
已完成
3 期
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate CancerProstate Cancer RecurrentProstate CancerNCT04742361ABX advanced biochemical compounds GmbH136
进行中（未招募）
1 期
18F-fluoride PET for Early Non-invasive Assessment of Cortical Bone Formation - Non-invasive Assessment of Cortical Bone Formation - Version 1EUCTR2009-016523-61-GBKing’s College London30